Workiva Inc is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The stock has some constructive momentum and strong long-term analyst support, but the chart is still technically weak, hedge funds are selling aggressively, and there is no fresh news catalyst. Based on the current data, I would not buy here; I would hold off for a clearer trend reversal or stronger entry point.
The technical picture is mixed to bearish. MACD is positive and expanding, which shows improving momentum, but RSI_6 at 47.249 is neutral and does not confirm strength. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, indicating the stock is still below a healthy uptrend structure. Price at 48.32 is slightly below the pivot of 48.889, with near support at 46.184 and resistance at 51.594. In short, momentum is trying to improve, but the trend is not yet strong enough for an immediate long-term buy.

Analysts remain broadly positive despite price-target cuts, and the company is still being viewed favorably for its growth and profitability trajectory. Raymond James cited strong Q1 revenue and earnings upside, improved profitability, larger deal sizes, strong retention, increasing AI adoption, and capital markets share gains. BTIG also highlighted constant-currency cRPO acceleration and underlying momentum. The option market is also leaning bullish, and the stock is showing short-term price improvement with a 3.65% regular-session gain and 0.82% pre-market follow-through.
There has been no fresh news in the last week, so there is no near-term catalyst driving the move. Hedge funds are selling heavily, with selling up 288.35% over the last quarter, which is a meaningful negative signal. Analyst price targets have been cut across the board, even though ratings stayed positive. Technically, the stock is still in a bearish moving-average structure, and similar candlestick analysis suggests a 60% chance of a -8.2% move the next day.
No usable latest-quarter financial snapshot was provided because of a data error, so a full financial assessment is not available. Based on the analyst commentary, the latest quarter appears to have been strong, with upside to revenue and earnings, improved profitability, and unchanged full-year growth outlook. The cited strength in subscription growth potential and margin expansion suggests the company is still growing in a healthy way, but the exact latest-quarter season and figures are not available in the data.
Wall Street is still constructive on Workiva. Raymond James, Baird, Stifel, and BTIG all kept Outperform/Buy ratings, but each lowered price targets, showing more cautious valuation expectations. The pros view: strong Q1 execution, retention, AI adoption, and margin expansion support the long-term story. The cons view: the lowered targets imply less upside in the near term, and the recent target cuts show analysts are tempering expectations despite staying bullish overall. No recent politician or congress trading activity was reported, so there is no influential-buyer/seller signal.